Laboratory for Developmental Neuropharmacology, McLean Hospital and Harvard Medical School Belmont, MA, USA ; Department of Psychiatry, McLean Hospital and Harvard Medical School Boston, MA, USA.
Department of Psychiatry, McLean Hospital and Harvard Medical School Boston, MA, USA.
Front Synaptic Neurosci. 2014 Jan 21;6:1. doi: 10.3389/fnsyn.2014.00001. eCollection 2014.
Early drug intervention in childhood disorders aims to maximize individual potential in the short- and long-term. Consistently, juvenile exposure to psychostimulants, such as methylphenidate (MPH), reduces risk for substance use in animals and sub-populations of individuals with attention deficit hyperactivity disorder (ADHD). We investigated the effects of MPH on brain plasticity via dopamine receptor D3 (D3R) and brain-derived neurotrophic factor (BDNF) expression in developing rats.
Between postnatal days 20-35, rat pups were administered saline vehicle (Veh) or MPH (2 mg/kg), the D3R-preferring agonist ±7-OHDPAT, or the antagonist nafadotride (0.05 mg/kg) alone, or in combination with MPH twice a day. In adulthood, subjects were challenged to Veh or cocaine (10 mg/kg for two days). The prefrontal cortex was analyzed for protein and mRNA levels of total BDNF, its splice variants I, IIc, III/IV, and IV/VI, and D3 receptors. A separate group of subjects was assessed for splice variants at 20, 35, 40, and 60 days of age.
Across age strong correlations were evident between Drd3 and Bdnf mRNA levels (r = 0.65) and a negative relationship between Drd3 and exon IIc after MPH treatment (r = -0.73). BDNF protein levels did not differ between Veh- and MPH subjects at baseline, but were significantly lower in MPH-treated and cocaine challenged subjects (30.3 ± 9.7%). Bdnf mRNA was significantly higher in MPH-treated subjects, and reversed upon exposure to cocaine. This effect was blocked by nafadotride. Furthermore, Bdnf total and Bdnf splice variants I, IIc, III/IV, and IV/VI changed across the transitions between juvenility and late adolescence.
These data suggest a sensitive window of vulnerability to modulation of BDNF expression around adolescence, and that compared to normal animals, juvenile exposure to MPH permanently reduces prefrontal BDNF transcription and translation upon cocaine exposure in adulthood by a D3R-mediated mechanism.
儿童期障碍的早期药物干预旨在最大限度地提高个体的短期和长期潜力。一致地,青少年接触哌甲酯(MPH)等精神兴奋剂可降低动物和注意力缺陷多动障碍(ADHD)亚群个体的物质使用风险。我们通过多巴胺受体 D3(D3R)和脑源性神经营养因子(BDNF)的表达研究了 MPH 对发育中大鼠大脑可塑性的影响。
在出生后第 20-35 天,给大鼠幼崽注射生理盐水载体(Veh)或 MPH(2mg/kg)、D3R 偏好激动剂±7-OHDPAT 或拮抗剂纳法曲肽(0.05mg/kg),单独或每天两次与 MPH 联合使用。在成年期,将这些动物用 Veh 或可卡因(10mg/kg,连用两天)进行挑战。对前额叶皮层进行总 BDNF、其剪接变体 I、IIc、III/IV 和 IV/VI 以及 D3 受体的蛋白和 mRNA 水平分析。另一组动物在 20、35、40 和 60 天时进行剪接变体评估。
在整个年龄范围内,Drd3 和 Bdnf mRNA 水平之间存在很强的相关性(r=0.65),并且在 MPH 治疗后,Drd3 和外显子 IIc 之间存在负相关(r=-0.73)。在基线时,Veh 和 MPH 组之间的 BDNF 蛋白水平没有差异,但在 MPH 处理和可卡因挑战的动物中显著降低(30.3±9.7%)。MPH 处理的动物的 Bdnf mRNA 水平显著升高,并且在接触可卡因后降低。纳法曲肽阻断了这种作用。此外,BDNF 总水平和 Bdnf 剪接变体 I、IIc、III/IV 和 IV/VI 在从青少年期到晚期青少年期的过渡过程中发生变化。
这些数据表明,BDNF 表达在青春期前后具有易感性窗口,并且与正常动物相比,青少年期接触 MPH 会通过 D3R 介导的机制永久性地降低成年期接触可卡因后的前额叶 BDNF 转录和翻译。